Details for New Drug Application (NDA): 216434
✉ Email this page to a colleague
The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 216434
Tradename: | BUMETANIDE |
Applicant: | Gland Pharma Ltd |
Ingredient: | bumetanide |
Patents: | 0 |
Pharmacology for NDA: 216434
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 216434
Suppliers and Packaging for NDA: 216434
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 216434 | ANDA | Fresenius Kabi USA, LLC | 65219-570 | 65219-570-04 | 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-570-04) / 4 mL in 1 VIAL, SINGLE-DOSE (65219-570-01) |
BUMETANIDE | bumetanide | INJECTABLE;INJECTION | 216434 | ANDA | Fresenius Kabi USA, LLC | 65219-572 | 65219-572-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (65219-572-10) / 10 mL in 1 VIAL, MULTI-DOSE (65219-572-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.25MG/ML | ||||
Approval Date: | May 26, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription